Cytochrome P450 2D6 Inhibitor Screening Kit
Cat.No. : | Kit-2135 |
Product Overview : | CYP2D6 Inhibitor Screening Kit enables rapid screening of drugs and other new chemical entities (NCEs) for compound-CYP2D6 interaction in a reliable, high-throughput fluorescence-based assay. The kit provides a yeast microsomal preparation of human CYP2D6 and cytochrome P450 reductase (CPR) enzymes. The assay utilizes a non-fluorescent CYP2D6-selective substrate that is converted into a highly fluorescent metabolite detected in the visible range (Ex/Em = 390/468 nm), ensuring a high signal-to-background ratio with little interference by autofluorescence. The kit contains a complete set of reagents sufficient for performing 200 reactions in a 96-well plate format. |
- Specification
- Gene Information
- Related Products
Size : | 200 assays |
Applications : | Rapid, high-throughput screening of drugs and novel ligands. Development of structure-activity relationship (SAR) models to predict CYP2D6 inhibition liability of novel compounds.Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2D6. |
Storage : | Store kit at -20°C and protected from light. Briefly centrifuge all small vials prior to opening. Allow the CYP2D6 Assay Buffer to warm to room temperature (RT) prior to use. Read entire protocol before performing the assay procedure.AHMC Standard: Reconstitute in 110 µl of DMSO and vortex until fully dissolved to yield a 2 mM stock solution. The AHMC stock solution should be stored at -20°C and is stable for at least 3 freeze/thaw cycles.CYP2D6 Inhibitor (Quinidine): Reconstitute in 220 µl of acetonitrile and vortex until fully dissolved to yield a 2 mM stock solution. The stock solution is stable for 2 months at -20°C. To obtain a 15 µM working solution of quinidine (5X final concentration), add 15 µl of the 2 mM stock solution to 1985 µl of CYP2D6 Assay Buffer. Store the 15 µM quinidine solution at -20°C and use within one week.NADPH Generating System (100X): Reconstitute with 220 µl CYP2D6 Assay Buffer, aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. Keep on ice while in use.β-NADP+ Stock (100X): Dissolve in 440 µl CYP2D6 Assay Buffer and vortex thoroughly (100X stock). Store at -20°C, stable for at least 3 freeze/thaw cycles.CYP2D6 Substrate: Reconstitute with 220 µl anhydrous HPLC-grade acetonitrile and vortex until fully dissolved. Store at -20°C. Whenusing the CYP2D6 Substrate stock solution, allow the vial to warm to RT before opening and promptly retighten cap after use to avoidabsorption of airborne moisture.Recombinant Human CYP2D6: The Recombinant Human CYP2D6 should be reconstituted immediately before use as directed in Protocol.2 below. Each vial is sufficient for one 96-well plate. |
Products Types
◆ Recombinant Protein | ||
CYP2D6-3401H | Recombinant Human CYP2D6 Protein, DDK-tagged | +Inquiry |
CYP2D6-49H | Active Recombinant Human CYP2D6 Protein | +Inquiry |
CYP2D6-0003H | Recombinant Human CYP2D6 Protein (P34-R497), Tag Free | +Inquiry |
CYP2D6-78H | Active Recombinant Human CYP2D6 Protein | +Inquiry |
CYP2D6-0004H | Recombinant Human CYP2D6 Protein (P34-R497), His tagged | +Inquiry |
◆ Lysates | ||
CYP2D6-7112HCL | Recombinant Human CYP2D6 293 Cell Lysate | +Inquiry |
◆ Assay kits | ||
Kit-2134 | Cytochrome P450 2D6 Fluorometric Activity Assay Kit | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionKnowing a patient's CYP2D6 genotype can help tailor drug therapy, optimizing dosage and minimizing the risk of adverse effects.
Genetic variations can result in different CYP2D6 phenotypes, influencing an individual's ability to metabolize drugs efficiently.
Certain ethnic groups may have a higher prevalence of CYP2D6 polymorphisms, influencing drug response variability among different populations.
CYP2D6 polymorphisms can lead to variations in drug response and efficacy, affecting the dosage and choice of medications for patients.
CYP2D6 testing can guide personalized medicine by helping clinicians choose the most appropriate medications and dosages for individual patients.
Customer Reviews (3)
Write a reviewOne remarkable aspect of working with the CYP2D6 protein is the excellent technical support provided by its manufacturer.
The CYP2D6 protein stands out as a protein of exceptional quality, perfectly suited to meet the experimental needs of researchers.
With its reliable performance and consistent results, the CYP2D6 protein provides researchers with the confidence and accuracy required for successful experimentation.
Ask a Question for All CYP2D6 Products
Required fields are marked with *
My Review for All CYP2D6 Products
Required fields are marked with *
Inquiry Basket